Copyright
©The Author(s) 2015.
World J Transplant. Dec 24, 2015; 5(4): 310-319
Published online Dec 24, 2015. doi: 10.5500/wjt.v5.i4.310
Published online Dec 24, 2015. doi: 10.5500/wjt.v5.i4.310
Figure 1 Evolution of kidney function during the study.
CrCl: Creatinine clearance; EVL: Everolimus.
- Citation: Manito N, Delgado JF, Crespo-Leiro MG, Arizón JM, Segovia J, González-Vílchez F, Mirabet S, Lage E, Pascual-Figal D, Díaz B, Palomo J, Rábago G, Sanz M, Blasco T, Roig E. Twelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipients. World J Transplant 2015; 5(4): 310-319
- URL: https://www.wjgnet.com/2220-3230/full/v5/i4/310.htm
- DOI: https://dx.doi.org/10.5500/wjt.v5.i4.310